Purple boxes that have been popping up across Maryland’s Mid-Shore over the past few years hold free supplies that could save a life, and advo…
From
To
Experts say that a promising drug that offers complete protection against HIV and requires only two shots a year isn't getting to enough people. Demand for lenacapavir is far outstripping supply in Uganda, other parts of Africa and all over the world. U.S. regulators on Monday approved a generic version for sale in low-income countries. That may help increase access in the coming months. But critics are calling on the drug's maker Gilead Sciences to offer it for sale at lower prices in more countries to help speed the rollout.
A West Point cadet drugged his girlfriend to force an unwanted abortion. Then he went to grad school
A onetime West Point cadet drugged his pregnant girlfriend in her barracks, gave her abortion pills while she was knocked out and caused a miscarriage. Then he went on to study at two Ivy League universities, starting at one of them after he pleaded guilty to assault. That's according to court records and a new lawsuit filed by the woman in New York last week. Caleb Suh pleaded guilty in June to the March 2022 assault. The victim was 19 at the time and in her second year at the U.S. Military Academy. Suh is scheduled to be sentenced in January.
A nurse prepares a syringe before injecting a patient with the new HIV prevention drug lenacapavir at the ART clinic at Mbarara City Council Health Center IV in western Uganda, Aug. 21, 2026. (AP Photo/Hajarah Nalwadda)
Patients wait for services at the ART clinic at Mbarara City Council Health Center IV in Mbarara, western Uganda, Aug. 21, 2026. (AP Photo/Hajarah Nalwadda)
A health worker registers patients at the ART clinic at Mbarara City Council Health Center IV in Mbarara, western Uganda, Aug. 21, 2026. (AP Photo/Hajarah Nalwadda)
The U.S. Food and Drug Administration has approved a generic version of the world’s only twice-a-year shot to prevent HIV. This is a big step toward making the extremely effective drug available inexpensively and quickly in 120 low- and middle-income countries. The drug, called lenacapavir, is expected to cost $40 a person each year in these places, the same price as daily preventive pills available now. But the shots are much more convenient than the pills because they’re needed much less frequently. The generic will not be available in the U.S. because there is a brand-name version still protected by a patent.
Lancaster County in Pennsylvania has been the epicenter of the nation's worst measles outbreak in 35 years. It's also home to the largest Amish population in the U.S. Some Amish and related Mennonite groups, with historically lower rates of vaccination, have been hit hard. Vaccination rates also declined in the general population amid the resurgence of a contagious virus considered “eliminated” from the U.S. since 2000. Pennsylvania leads the U.S. this year with over 1,350 cases, more than a third in Lancaster County, according to official figures. Many Amish and Mennonites are showing a new openness to vaccines, while members of the general public are also taking extra precautions.
AP
The NFL and NFL Players Association are working together to review the handling of Jalen Hurts’ blood clot diagnosis. The league and players’ union released a joint statement Sunday saying they are looking into it after the NFLPA called for an investigation earlier in the week. Hurts was placed on injured reserve and is expected to miss the rest of the season after a blood clot in his left calf traveled to his lungs. The Eagles and agent Nicole Lynn said Monday that Hurts has deep vein thrombosis and bilateral pulmonary emboli. His treatment involves blood thinners, and Hurts won't be allowed to participate in any football activities until he is off them.
Cindy Banda drinks a home remedy after experiencing side effects from the targeted therapy pill Kisqali, Sept. 16, 2026, at her house in McAllen, Texas. (AP Photo/Julia Demaree Nikhinson)